LONDON, February 26 /PRNewswire/ --

- With Photo

I care for my body were delighted to be the chosen aesthetic facility to undertake the physical transformations of 80s pop idols; Dollar, The Original Bucks Fizz, Visage, 911, Shakatak and Cleopatra, for Pop Goes The Band airing on LIVING this spring.

With nine Cosmetic Surgery and Aesthetic Centres worldwide, I care for my body is a visionary provider of aesthetic excellence, dedicated to transforming the lives of patients through a combination of the latest surgical and non-invasive techniques; including the groundbreaking non-surgical treatments Ultrashape, Accent RF and Rioblush Carboxy Therapy.

The detailed structure of a protective 'jacket' that surrounds cells of the Clostridium difficile superbug, and which helps the dangerous pathogen stick to human host cells and tissues, is revealed in part in the 1 March issue of Molecular Microbiology. 

Scientists hope that unravelling the secrets of this protective layer's molecular structure might reveal possible targets for new drugs to treat C. difficile infections.

The 'jacket' is a surface layer, or 'S-layer', made of two different proteins, with half a million of each covering every C. difficile cell. The S-layer is believed to help C. difficile cells colonise the human gut, where they release sickness-causing toxins. 

Mendel solved the logic of inheritance in his monastery garden with no more technology than Darwin had in his garden at Down House, so why couldn't Darwin have done it too? A Journal of Biology article argues that Darwin's background, influences and research focus gave him a viewpoint that prevented him from interpreting the evidence that was all around him, even in his own work. 

Moravian priest and scientist Gregor Mendel (1822 - 1884) studied clear-cut, inherited traits in pea plants, which he grew in the monastery gardens in Brno. Mendel showed that trait inheritance follows simple laws, and 'Mendels Laws Of Inheritance' (1) were later named after him. Mendel's work was rediscovered at the beginning of the 20th century, and laid the foundations for genetics.

SAN RAMON, California, February 27 /PRNewswire/ --

- Energy Providers from Numerous Countries Gain Insight on Industry Leading ZigBee Technology

ZigBee welcomed more than 120 representatives of European governments, utilities and energy services companies to its European Smart Energy Forum in Dublin, Ireland on February 13, 2009. Coming on the heels of its 27th member meeting, the Forum demonstrated end-to-end applications of ZigBee networking and ZigBee Smart Energy, including smart meters and mesh networked backhaul technologies, as well as ZigBee thermostats and in-home displays in a user- friendly forum for energy providers.

PALO ALTO, California, February 26 /PRNewswire/ --

- Funding to advance novel Hepatitis C Virus (HCV) therapies against new targets

Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised US$7.1 million in a Series A financing co-led by InterWest Partners and Vivo Ventures. The funding will advance the company's lead program targeted against NS4B, a specific region in the hepatitis C virus (HCV) protein.

BARCELONA, February 26 /PRNewswire/ -- Prous Institute for Biomedical Research today presented its strategies for drug discovery on its newly designed website (http://www.prousresearch.com). A large computational project with basic research support and broad disease coverage is being developed at Prous Institute under the broad-based Epistemic Drug Discovery(R) project.

President and C.E.O. of the Institute, Dr. J.R. Prous, explained that We are committed to accelerating biomedical knowledge by the synchronization of powerful expert knowledge-based systems and basic research. This next-generation drug RD force is expected to increase the efficiency and efficacy of core drug RD processes, facilitating continuous innovation.

ROUSSET, France and TAIPEI, Taiwan, February 26 /PRNewswire/ --

- Illustrates Ease and Rapidity of CAP Application Development; JPEG Compression and De-compression IP available from PGC

Atmel(R) Corporation (Nasdaq: ATML) and PGC (Progate Group Corporation) announced today the availability of a JPEG image viewer reference design ported onto the low-cost AT91CAP9A-STK Starter Kit for Atmel's AT91CAP9S Customizable Microcontroller. When connected to a host PC via its USB Device Port, the CAP-STK appears as a mass storage device for JPEG images. Running stand-alone, the CAP-STK de-compresses the images and displays them on its VGA screen, using JPEG de-compression and display IP supplied by PGC, and mapped into the FPGA that emulates CAP's Metal Programmable block.